anyone else notice oral GLP-1 kicking in around week 56
Here it is: anyone else notice oral GLP-1 kicking in around week 56. One person, one log, no control group, so read it accordingly. Why "oral" is doing two completely different jobs in the sentences people write here. Oral semaglutide is a peptide co-formulated with an absorption enhancer, which is why it comes with…
Standing reminder: unapproved compound, research material is not for human use, and no schedules for other members.
Milligram-for-milligram comparison with an injectable peptide is not meaningful and I should not have made it.
oral and non-peptide is the whole engineering story
Yes. Oral peptide with an absorption enhancer and oral small molecule are completely different propositions.
Right, and comparing milligrams between a small molecule and a peptide is meaningless in either direction.
Yes — nothing containing this is approved anywhere, and the threads keep forgetting it.
Nothing containing this compound is approved by any regulator, and research-use-only material is not approved for human use.
Small fix — the two programme names got swapped upthread and it changes which population the figure came from.
Which programme and which readout are you quoting?
oral semaglutide is a peptide with an absorption enhancer, this is not that